CA
RTO icon

Continuum Advisory’s Rentokil RTO Stock Holding History

Continuum Advisory’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-113
Closed -$2.59K – 1335
2025
Q1 		$2.59K Sell
113
-54
-32% -$1.3K ﹤0.01% 1260
2024
Q4 		$4.23K Buy
167
+28
+20% +$710 ﹤0.01% 1181
2024
Q3 		$3.56K Buy
139
+35
+34% +$1.04K ﹤0.01% 1252
2024
Q2 		$3.08K Hold
104
– – ﹤0.01% 1195
2024
Q1 		$2.79K Buy
+104
New +$2.89K ﹤0.01% 1208

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Continuum Advisory's RTO Position: Q2 2025 in Review

Continuum Advisory sold out of Rentokil (RTO) in Q2 2025, closing a stake of 113 shares — an estimated $2.59K sold.

Continuum Advisory first reported a position in RTO in Q1 2024 and held it in 5 quarters. The position peaked at $4.23K in Q4 2024. 205 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • Continuum Advisory reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 113 Rentokil shares in Q2 2025, an estimated $2.59K.
  • Continuum Advisory first reported a position in Rentokil in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Rentokil position peaked at $4.23K in Q4 2024.
  • 205 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.